Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thilo Witsch is active.

Publication


Featured researches published by Thilo Witsch.


Journal of Thrombosis and Haemostasis | 2016

Neutrophil elastase-deficient mice form neutrophil extracellular traps in an experimental model of deep vein thrombosis

Kimberly Martinod; Thilo Witsch; Kalamo Farley; Maureen Gallant; Eileen Remold-O'Donnell; Denisa D. Wagner

Essentials Neutrophil elastase (NE) plays a role in extracellular trap formation (NETosis) triggered by microbes. The contribution of NE was evaluated in mouse NETosis models of sterile inflammation and thrombosis. NE is not required for mouse neutrophil NET production in vitro with non‐infectious stimuli. NE deficiency had no significant effect on thrombosis in the inferior vena cava stenosis model.


Circulation | 2014

Dual-Contrast Molecular Imaging Allows Noninvasive Characterization of Myocardial Ischemia/Reperfusion Injury After Coronary Vessel Occlusion in Mice by Magnetic Resonance Imaging

D. von Elverfeldt; Alexander Maier; Daniel Duerschmied; Moritz Braig; Thilo Witsch; Xiaowei Wang; Maximilian Mauler; Irene Neudorfer; Marius Menza; Marco Idzko; A. Zirlik; T. Heidt; Peter Bronsert; Christoph Bode; Karlheinz Peter; C. von zur Muhlen

Background— Inflammation and myocardial necrosis play important roles in ischemia/reperfusion injury after coronary artery occlusion and recanalization. The detection of inflammatory activity and the extent of myocardial necrosis itself are of great clinical and prognostic interest. We developed a dual, noninvasive imaging approach using molecular magnetic resonance imaging in an in vivo mouse model of myocardial ischemia and reperfusion. Methods and Results— Ischemia/reperfusion injury was induced in 10-week-old C57BL/6N mice by temporary ligation of the left anterior descending coronary artery. Activated platelets were targeted with a contrast agent consisting of microparticles of iron oxide (MPIOs) conjugated to a single-chain antibody directed against a ligand-induced binding site (LIBS) on activated glycoprotein IIb/IIIa (LIBS-MPIOs). After injection and imaging of LIBS-MPIOs, late gadolinium enhancement was used to depict myocardial necrosis; these imaging experiments were also performed in P2Y12−/− mice. All imaging results were correlated to immunohistochemistry findings. Activated platelets were detectable by magnetic resonance imaging via a significant signal effect caused by LIBS-MPIOs in the area of left anterior descending coronary artery occlusion 2 hours after reperfusion. In parallel, late gadolinium enhancement identified the extent of myocardial necrosis. Immunohistochemistry confirmed that LIBS-MPIOs bound significantly to microthrombi in reperfused myocardium. Only background binding was found in P2Y12−/− mice. Conclusions— Dual molecular imaging of myocardial ischemia/reperfusion injury allows characterization of platelet-driven inflammation by LIBS-MPIOs and myocardial necrosis by late gadolinium enhancement. This noninvasive imaging strategy is of clinical interest for both diagnostic and prognostic purposes and highlights the potential of molecular magnetic resonance imaging for characterizing ischemia/reperfusion injury.


Journal of Experimental Medicine | 2017

Peptidylarginine deiminase 4 promotes age-related organ fibrosis

Kimberly Martinod; Thilo Witsch; Luise Erpenbeck; Alexander S. Savchenko; Hideki Hayashi; Deya Cherpokova; Maureen Gallant; Maximilian Mauler; Stephen M. Cifuni; Denisa D. Wagner

Aging promotes inflammation, a process contributing to fibrosis and decline in organ function. The release of neutrophil extracellular traps (NETs [NETosis]), orchestrated by peptidylarginine deiminase 4 (PAD4), damages organs in acute inflammatory models. We determined that NETosis is more prevalent in aged mice and investigated the role of PAD4/NETs in age-related organ fibrosis. Reduction in fibrosis was seen in the hearts and lungs of aged PAD4−/− mice compared with wild-type (WT) mice. An increase in left ventricular interstitial collagen deposition and a decline in systolic and diastolic function were present only in WT mice, and not in PAD4−/− mice. In an experimental model of cardiac fibrosis, cardiac pressure overload induced NETosis and significant platelet recruitment in WT but not PAD4−/− myocardium. DNase 1 was given to assess the effects of extracellular chromatin. PAD4 deficiency or DNase 1 similarly protected hearts from fibrosis. We propose a role for NETs in cardiac fibrosis and conclude that PAD4 regulates age-related organ fibrosis and dysfunction.


Circulation | 2014

Dual Contrast Molecular Imaging Allows Noninvasive Characterization of Myocardial Ischemia/Reperfusion Injury After Coronary Vessel Occlusion in Mice by MRI

Dominik von Elverfeldt; Alexander Maier; Daniel Duerschmied; Moritz Braig; Thilo Witsch; Xiaowei Wang; Maximilian Mauler; Irene Neudorfer; Marius Menza; Marco Idzko; Andreas Zirlik; Timo Heidt; Peter Bronsert; Christoph Bode; Karlheinz Peter; Constantin von zur Muhlen

Background— Inflammation and myocardial necrosis play important roles in ischemia/reperfusion injury after coronary artery occlusion and recanalization. The detection of inflammatory activity and the extent of myocardial necrosis itself are of great clinical and prognostic interest. We developed a dual, noninvasive imaging approach using molecular magnetic resonance imaging in an in vivo mouse model of myocardial ischemia and reperfusion. Methods and Results— Ischemia/reperfusion injury was induced in 10-week-old C57BL/6N mice by temporary ligation of the left anterior descending coronary artery. Activated platelets were targeted with a contrast agent consisting of microparticles of iron oxide (MPIOs) conjugated to a single-chain antibody directed against a ligand-induced binding site (LIBS) on activated glycoprotein IIb/IIIa (LIBS-MPIOs). After injection and imaging of LIBS-MPIOs, late gadolinium enhancement was used to depict myocardial necrosis; these imaging experiments were also performed in P2Y12−/− mice. All imaging results were correlated to immunohistochemistry findings. Activated platelets were detectable by magnetic resonance imaging via a significant signal effect caused by LIBS-MPIOs in the area of left anterior descending coronary artery occlusion 2 hours after reperfusion. In parallel, late gadolinium enhancement identified the extent of myocardial necrosis. Immunohistochemistry confirmed that LIBS-MPIOs bound significantly to microthrombi in reperfused myocardium. Only background binding was found in P2Y12−/− mice. Conclusions— Dual molecular imaging of myocardial ischemia/reperfusion injury allows characterization of platelet-driven inflammation by LIBS-MPIOs and myocardial necrosis by late gadolinium enhancement. This noninvasive imaging strategy is of clinical interest for both diagnostic and prognostic purposes and highlights the potential of molecular magnetic resonance imaging for characterizing ischemia/reperfusion injury.


PLOS ONE | 2014

Acute fluoxetine treatment induces slow rolling of leukocytes on endothelium in mice.

Nadine Herr; Maximilian Mauler; Thilo Witsch; Daniela Stallmann; Stefanie Schmitt; Julius Mezger; Christoph Bode; Daniel Duerschmied

Objective Activated platelets release serotonin at sites of inflammation where it acts as inflammatory mediator and enhances recruitment of neutrophils. Chronic treatment with selective serotonin reuptake inhibitors (SSRI) depletes the serotonin storage pool in platelets, leading to reduced leukocyte recruitment in murine experiments. Here, we examined the direct and acute effects of SSRI on leukocyte recruitment in murine peritonitis. Methods C57Bl/6 and Tph1−/− (Tryptophan hydroxylase1) mice underwent acute treatment with the SSRI fluoxetine or vehicle. Serotonin concentrations were measured by ELISA. Leukocyte rolling and adhesion on endothelium was analyzed by intravital microscopy in mesentery venules with and without lipopolysaccharide challenge. Leukocyte extravasation in sterile peritonitis was measured by flow cytometry of abdominal lavage fluid. Results Plasma serotonin levels were elevated 2 hours after fluoxetine treatment (0.70±0.1 µg/ml versus 0.27±0.1, p = 0.03, n = 14), while serum serotonin did not change. Without further stimulation, acute fluoxetine treatment increased the number of rolling leukocytes (63±8 versus 165±17/0.04 mm2min−1) and decreased their velocity (61±6 versus 28±1 µm/s, both p<0.0001, n = 10). In Tph1−/− mice leukocyte rolling was not significantly influenced by acute fluoxetine treatment. Stimulation with lipopolysaccharide decreased rolling velocity and induced leukocyte adhesion, which was enhanced after fluoxetine pretreatment (27±3 versus 36±2/0.04 mm2, p = 0.008, n = 10). Leukocyte extravasation in sterile peritonitis, however, was not affected by acute fluoxetine treatment. Conclusions Acute fluoxetine treatment increased plasma serotonin concentrations and promoted leukocyte-endothelial interactions in-vivo, suggesting that serotonin is a promoter of acute inflammation. E-selectin was upregulated on endothelial cells in the presence of serotonin, possibly explaining the observed increase in leukocyte-endothelial interactions. However transmigration of neutrophils in sterile peritonitis was not affected by higher serotonin concentrations, indicating that the effect of fluoxetine was restricted to early steps in the leukocyte recruitment. Whether SSRI use in humans alters leukocyte recruitment remains to be investigated.


Journal of Thrombosis and Haemostasis | 2013

Contrast ultrasound for the quantification of deep vein thrombosis in living mice: effects of enoxaparin and P2Y12 receptor inhibition

Felix Guenther; Nadine Herr; Maximilian Mauler; Thilo Witsch; Freya Roming; Lutz Hein; Jean-Marie Boeynaems; B. Robaye; Marco Idzko; Christoph Bode; C. Von Zur Muhlen; Daniel Duerschmied

We examined the applicability of contrast‐enhanced ultrasound (CEUS) for imaging of murine deep vein thrombosis (DVT) and measured the effects of enoxaparin, ticagrelor and P2Y12 receptor deficiency in vivo.


Journal of Neurology | 2011

Rituximab in c-ANCA associated vasculitic polyneuropathy complicated by local peritonitis

Jens Witsch; Werner Stenzel; Thilo Witsch; Johann S. Braun; George Trendelenburg

A 70-year-old woman presented with progressive weakness over 3 weeks and paresthesia of the lower extremities. Except for a recent history of recurrent respiratory tract infections, she had been healthy previously. Within hours after hospital admission, paresis progressed markedly, and she required intensive care. Physical examination showed sensory-motor polyneuropathy with tetraplegia and symmetrical distal sensory impairment of all extremities, no cranial nerve abnormalities nor autonomous dysregulation. Because of involvement of the diaphragm the patient was intubated and ventilated. The clinical presentation was suggestive of Guillain–Barre syndrome (GBS). CSF examination revealed 92 WBC/ll, 33,700 erythrocytes/ll, glucose 69 mg/dl, lactate 35.4 mg/dl and protein 181 mg/dl. Electrophysiology was consistent with a sensorymotor polyneuropathy with axonal affection. A cranial MRI demonstrated central nervous system involvement (Fig. 1g–i). Laboratory testings showed an elevated c-antineutrophil cytoplasmic antibodies (c-ANCA)-titer (168 U/ml) and slightly elevated creatinine. In synopsis with the patient’s history of recurrent respiratory infections, Wegener’s granulomatosis with vasculitic polyneuropathy and central nervous system involvement was suspected and confirmed by sural nerve biopsy (Fig. 1a–f), as well as skin , and nasopharyngeal mucosa biopsy (not shown). High-dose steroids, plasmapheresis, and intravenous immunoglobulins were sequentially administered without improving the patient’s symptoms. Then a severe lower gastro-intestinal bleeding, which eventually required surgical removal of the ileocecum complicated the clinical course. Histology, it revealed no signs of vasculitis, but a disseminated cryptitis of the colon. Subsequently, the patient developed a localized peritonitis due to abdominal wound healing disturbance and dehiscence, warranting multiple surgical revisions. Meanwhile, the patient’s neurological and pulmonary status remained unchanged. Because therapy-escalation seemed mandatory, administration of rituximab (dose: 375 mg/m in 4 weekly courses) was preferred to cyclophosphamide, which is described to worsen wound healing [1]. Remarkably, under rituximab, the abdominal infection did not recur and the patient’s condition improved substantially. Ten weeks after admission, the patient could be weaned off the ventilator and transferred to the general ward. Within the following weeks, muscle strength in the upper, and later on in the lower extremities, recurred and the patient was transferred to rehabilitation. The patient was able to touch her nose with the left hand and to lift up her right hand against gravity. Both legs could be elevated against gravity but she was still unable to walk. The neurological improvement was quantified using the Wegener’s J. Witsch (&) J. Braun G. Trendelenburg Department of Neurology, Charite University Medicine, Campus Virchow Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany e-mail: [email protected]


PLOS ONE | 2017

Sirt3 deficiency does not affect venous thrombosis or NETosis despite mild elevation of intracellular ROS in platelets and neutrophils in mice

Hideki Hayashi; Deya Cherpokova; Kimberly Martinod; Thilo Witsch; Siu Ling Wong; Maureen Gallant; Stephen M. Cifuni; Leonard Guarente; Denisa D. Wagner

Inflammation is a common denominator in chronic diseases of aging. Yet, how inflammation fuels these diseases remains unknown. Neutrophils are the primary leukocytes involved in the early phase of innate immunity and inflammation. As part of their anti-microbial defense, neutrophils form extracellular traps (NETs) by releasing decondensed chromatin lined with cytotoxic proteins. NETs have been shown to induce tissue injury and thrombosis. Here, we demonstrated that Sirt3, a nicotinamide adenine dinucleotide (NAD+)-dependent protein deacetylase, an enzyme linked to human longevity, was expressed in mouse neutrophils and platelets. Using Sirt3-/- mice as a model of accelerated aging, we investigated the effects of Sirt3 deficiency on NETosis and platelet function, aiming to detect enhancement of thrombosis. More mitochondrial reactive oxygen species (ROS) were generated in neutrophils and platelets of Sirt3-/- mice compared to WT, when stimulated with a low concentration of phorbol 12-myristate 13-acetate (PMA) and a high concentration of thrombin, respectively. There were no differences in in vitro NETosis, with or without stimulation. Platelet aggregation was mildly augmented in Sirt3-/- mice compared to WT mice, when stimulated with a low concentration of collagen. The effect of Sirt3 deficiency on platelet and neutrophil activation in vivo was examined by the venous thrombosis model of inferior vena cava stenosis. Elevation of plasma DNA concentration was observed after stenosis in both genotypes, but no difference was shown between the two genotypes. The systemic response to thrombosis was enhanced in Sirt3-/- mice with significantly elevated neutrophil count and reduced platelet count. However, no differences were observed in incidence of thrombus formation, thrombus weight and thrombin-antithrombin complex generation between WT and Sirt3-/- mice. We conclude that Sirt3 does not considerably impact NET formation, platelet function, or venous thrombosis in healthy young mice.


Journal of the American Heart Association | 2018

Recombinant Human ADAMTS13 Treatment Improves Myocardial Remodeling and Functionality After Pressure Overload Injury in Mice

Thilo Witsch; Kimberly Martinod; Nicoletta Sorvillo; Irina Portier; Simon F. De Meyer; Denisa D. Wagner

Background A disintegrin‐like metalloproteinase with thrombospondin motif type 1 member 13 (ADAMTS13), the von Willebrand factor–cleaving enzyme, decreases leukocyte and platelet recruitment and, thus, reduces thrombosis and inflammation. Recombinant human ADAMTS13 (rhADAMTS13) is a novel drug candidate for ischemia/reperfusion injury and has shown short‐term benefits in mouse models of myocardial injury, but long‐term outcome has not been investigated. Methods and Results We evaluated the impact of rhADAMTS13 on cardiac remodeling, scarring, and contractile function, under chronic left ventricular pressure overload. The role of von Willebrand factor and the effect of rhADAMTS13 treatment were studied. This model of heart failure, based on ascending aortic constriction, produces a coronary inflammatory response and microvascular dysfunction, resulting in fibrotic remodeling and cardiac failure. Mice were treated with either rhADAMTS13 or vehicle and assessed for coronary vascular inflammation and ventricular function at several postsurgical time points, as well as for cardiac fibrosis after 4 weeks. Early upon induction of pressure overload under rhADAMTS13 treatment, we detected less endothelial‐lumen–associated von Willebrand factor, fewer platelet aggregates, and decreased activated transforming growth factor‐β1 levels than in vehicle‐treated mice. We observed significant preservation of cardiac function and decrease in fibrotic remodeling as a result of rhADAMTS13 administration. Conclusions Herein, we show that rhADAMTS13 decreases coronary vascular dysfunction and improves cardiac remodeling after left ventricular pressure overload in mice. We propose that this effect may, at least in part, be the result of decreased von Willebrand factor–mediated recruitment of platelets, a major source of the activated profibrotic cytokine transforming growth factor‐β1. Our study further supports the therapeutic potential of rhADAMTS13 for conditions characterized by inflammatory cardiac damage that results in fibrosis.


PLOS ONE | 2015

Correction: Acute Fluoxetine Treatment Induces Slow Rolling of Leukocytes on Endothelium in Mice.

Nadine Herr; Maximilian Mauler; Thilo Witsch; Daniela Stallmann; Stefanie Schmitt; Julius Mezger; Christoph Bode; Daniel Duerschmied

The following funder is missing from the Funding section: Deutsche Herzstiftung. The correct funding information is as follows: This work was funded by the Deutsche Forschungsgemeinschaft (DFG) and the Deutsche Herzstiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Collaboration


Dive into the Thilo Witsch's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nadine Herr

University of Freiburg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Denisa D. Wagner

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Kimberly Martinod

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Marco Idzko

University of Freiburg

View shared research outputs
Top Co-Authors

Avatar

Maureen Gallant

Memorial University of Newfoundland

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge